226 related articles for article (PubMed ID: 10474118)
1. Final height in young women with Turner syndrome after GH therapy: an open controlled study.
Hochberg Z; Zadik Z
Eur J Endocrinol; 1999 Sep; 141(3):218-24. PubMed ID: 10474118
[TBL] [Abstract][Full Text] [Related]
2. Final height in Turner syndrome patients treated with growth hormone.
Pasquino AM; Passeri F; Municchi G; Segni M; Pucarelli I; Larizza D; Bossi G; Severi F; Galasso C
Horm Res; 1996; 46(6):269-72. PubMed ID: 8982737
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group.
Chernausek SD; Attie KM; Cara JF; Rosenfeld RG; Frane J
J Clin Endocrinol Metab; 2000 Jul; 85(7):2439-45. PubMed ID: 10902791
[TBL] [Abstract][Full Text] [Related]
4. Final Adult Height after Growth Hormone Treatment in Patients with Turner Syndrome.
Ahn JM; Suh JH; Kwon AR; Chae HW; Kim HS
Horm Res Paediatr; 2019; 91(6):373-379. PubMed ID: 31480041
[TBL] [Abstract][Full Text] [Related]
5. A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis.
Johnston DI; Betts P; Dunger D; Barnes N; Swift PG; Buckler JM; Butler GE
Arch Dis Child; 2001 Jan; 84(1):76-81. PubMed ID: 11124794
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term (final height) growth responses to growth hormone (GH) therapy in patients with Turner syndrome: correlation of growth response to stimulated GH levels, spontaneous GH secretion, and karyotype.
Schmitt K; Haeusler G; Blümel P; Plöchl E; Frisch H
Horm Res; 1997; 47(2):67-72. PubMed ID: 9030970
[TBL] [Abstract][Full Text] [Related]
7. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
[TBL] [Abstract][Full Text] [Related]
8. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
Stahnke N; Keller E; Landy H;
J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
[TBL] [Abstract][Full Text] [Related]
9. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
[TBL] [Abstract][Full Text] [Related]
10. Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD.
Hasegawa Y; Ariyasu D; Izawa M; Igaki-Miyamoto J; Fukuma M; Hatano M; Yagi H; Goto M
Endocr J; 2017 Feb; 64(2):221-227. PubMed ID: 27916781
[TBL] [Abstract][Full Text] [Related]
11. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome.
Rosenfield RL; Devine N; Hunold JJ; Mauras N; Moshang T; Root AW
J Clin Endocrinol Metab; 2005 Dec; 90(12):6424-30. PubMed ID: 16189255
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
[TBL] [Abstract][Full Text] [Related]
13. Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Massa GG; Rouwe CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1999 Dec; 84(12):4607-12. PubMed ID: 10599727
[TBL] [Abstract][Full Text] [Related]
14. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
[TBL] [Abstract][Full Text] [Related]
15. Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group.
Pasquino AM; Pucarelli I; Segni M; Tarani L; Calcaterra V; Larizza D
J Endocrinol Invest; 2005 Apr; 28(4):350-6. PubMed ID: 15966509
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone treatment regimens in girls with Turner syndrome. Dutch Advisory Group on Growth Hormone.
de Muinck Keizer-Schrama SM; Sas TC
Acta Paediatr Suppl; 1999 Dec; 88(433):126-9. PubMed ID: 10626563
[TBL] [Abstract][Full Text] [Related]
17. Pubertal height gain in Ullrich-Turner syndrome.
Bechtold S; Dalla Pozza R; Schmidt H; Bonfig W; Schwarz HP
J Pediatr Endocrinol Metab; 2006 Aug; 19(8):987-93. PubMed ID: 16995583
[TBL] [Abstract][Full Text] [Related]
18. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
[TBL] [Abstract][Full Text] [Related]
19. Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome.
Davenport ML
Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S91-7. PubMed ID: 16735135
[TBL] [Abstract][Full Text] [Related]
20. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
Cacciari E; Mazzanti L
J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
